Cyclin D1 splice variants: Differential effects on localization, RB phosphorylation, and cellular transformation

David A. Solomon, Ying Wang, Sejal R. Fox, Tah C. Lambeck, Sarah Giesting, Zhengdao Lan, Adrian M. Senderowicz, Erik S. Knudsen

Research output: Contribution to journalArticle

181 Citations (Scopus)

Abstract

Cyclin D1 is a proto-oncogene that functions by inactivation of the retinoblastoma tumor suppressor protein, RB. A common polymorphism in the cyclin D1 gene is associated with the production of an alternate transcript of cyclin D1, termed cyclin D1b. Both the polymorphism and the variant transcript are associated with increased risk for multiple cancers and the severity of a given cancer; however, the underlying activities of cyclin D1b have not been elucidated relative to the canonical cyclin D1a. Because cyclin D1b does not possess the threonine 286 phosphorylation site required for nuclear export and regulated degradation, it has been hypothesized to encode a stable nuclear protein that would constitutively inactivate the RB pathway. Surprisingly, we find that cyclin D1b protein does not inappropriately accumulate in cells and exhibits stability comparable to cyclin D1a. As expected, the cyclin D1b protein was constitutively localized in the nucleus, whereas cyclin D1a was exported to the cytoplasm in S-phase. Despite enhanced nuclear localization, we find that cyclin D1b is a poor catalyst of RB phosphorylation/inactivation. However, cyclin D1b potently induced cellular transformation in contrast to cyclin D1a. In summary, we demonstrate that cyclin D1b specifically disrupts contact inhibition in a manner distinct from cyclin D1a. These data reveal novel roles for D-type cyclins in tumorigenesis.

Original languageEnglish (US)
Pages (from-to)30339-30347
Number of pages9
JournalJournal of Biological Chemistry
Volume278
Issue number32
DOIs
StatePublished - Aug 8 2003

Fingerprint

Phosphorylation
Cyclins
Cyclin D1
Polymorphism
bcl-1 Genes
Contact Inhibition
Cyclin D
Tumor Suppressor Proteins
Retinoblastoma Protein
Cell Nucleus Active Transport
Proto-Oncogenes
Threonine
Nuclear Proteins
S Phase
Neoplasms
Carcinogenesis
Cytoplasm
Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Solomon, D. A., Wang, Y., Fox, S. R., Lambeck, T. C., Giesting, S., Lan, Z., ... Knudsen, E. S. (2003). Cyclin D1 splice variants: Differential effects on localization, RB phosphorylation, and cellular transformation. Journal of Biological Chemistry, 278(32), 30339-30347. https://doi.org/10.1074/jbc.M303969200

Cyclin D1 splice variants : Differential effects on localization, RB phosphorylation, and cellular transformation. / Solomon, David A.; Wang, Ying; Fox, Sejal R.; Lambeck, Tah C.; Giesting, Sarah; Lan, Zhengdao; Senderowicz, Adrian M.; Knudsen, Erik S.

In: Journal of Biological Chemistry, Vol. 278, No. 32, 08.08.2003, p. 30339-30347.

Research output: Contribution to journalArticle

Solomon, DA, Wang, Y, Fox, SR, Lambeck, TC, Giesting, S, Lan, Z, Senderowicz, AM & Knudsen, ES 2003, 'Cyclin D1 splice variants: Differential effects on localization, RB phosphorylation, and cellular transformation', Journal of Biological Chemistry, vol. 278, no. 32, pp. 30339-30347. https://doi.org/10.1074/jbc.M303969200
Solomon, David A. ; Wang, Ying ; Fox, Sejal R. ; Lambeck, Tah C. ; Giesting, Sarah ; Lan, Zhengdao ; Senderowicz, Adrian M. ; Knudsen, Erik S. / Cyclin D1 splice variants : Differential effects on localization, RB phosphorylation, and cellular transformation. In: Journal of Biological Chemistry. 2003 ; Vol. 278, No. 32. pp. 30339-30347.
@article{150a376163074ceda7e085d36c7b7473,
title = "Cyclin D1 splice variants: Differential effects on localization, RB phosphorylation, and cellular transformation",
abstract = "Cyclin D1 is a proto-oncogene that functions by inactivation of the retinoblastoma tumor suppressor protein, RB. A common polymorphism in the cyclin D1 gene is associated with the production of an alternate transcript of cyclin D1, termed cyclin D1b. Both the polymorphism and the variant transcript are associated with increased risk for multiple cancers and the severity of a given cancer; however, the underlying activities of cyclin D1b have not been elucidated relative to the canonical cyclin D1a. Because cyclin D1b does not possess the threonine 286 phosphorylation site required for nuclear export and regulated degradation, it has been hypothesized to encode a stable nuclear protein that would constitutively inactivate the RB pathway. Surprisingly, we find that cyclin D1b protein does not inappropriately accumulate in cells and exhibits stability comparable to cyclin D1a. As expected, the cyclin D1b protein was constitutively localized in the nucleus, whereas cyclin D1a was exported to the cytoplasm in S-phase. Despite enhanced nuclear localization, we find that cyclin D1b is a poor catalyst of RB phosphorylation/inactivation. However, cyclin D1b potently induced cellular transformation in contrast to cyclin D1a. In summary, we demonstrate that cyclin D1b specifically disrupts contact inhibition in a manner distinct from cyclin D1a. These data reveal novel roles for D-type cyclins in tumorigenesis.",
author = "Solomon, {David A.} and Ying Wang and Fox, {Sejal R.} and Lambeck, {Tah C.} and Sarah Giesting and Zhengdao Lan and Senderowicz, {Adrian M.} and Knudsen, {Erik S.}",
year = "2003",
month = "8",
day = "8",
doi = "10.1074/jbc.M303969200",
language = "English (US)",
volume = "278",
pages = "30339--30347",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "32",

}

TY - JOUR

T1 - Cyclin D1 splice variants

T2 - Differential effects on localization, RB phosphorylation, and cellular transformation

AU - Solomon, David A.

AU - Wang, Ying

AU - Fox, Sejal R.

AU - Lambeck, Tah C.

AU - Giesting, Sarah

AU - Lan, Zhengdao

AU - Senderowicz, Adrian M.

AU - Knudsen, Erik S.

PY - 2003/8/8

Y1 - 2003/8/8

N2 - Cyclin D1 is a proto-oncogene that functions by inactivation of the retinoblastoma tumor suppressor protein, RB. A common polymorphism in the cyclin D1 gene is associated with the production of an alternate transcript of cyclin D1, termed cyclin D1b. Both the polymorphism and the variant transcript are associated with increased risk for multiple cancers and the severity of a given cancer; however, the underlying activities of cyclin D1b have not been elucidated relative to the canonical cyclin D1a. Because cyclin D1b does not possess the threonine 286 phosphorylation site required for nuclear export and regulated degradation, it has been hypothesized to encode a stable nuclear protein that would constitutively inactivate the RB pathway. Surprisingly, we find that cyclin D1b protein does not inappropriately accumulate in cells and exhibits stability comparable to cyclin D1a. As expected, the cyclin D1b protein was constitutively localized in the nucleus, whereas cyclin D1a was exported to the cytoplasm in S-phase. Despite enhanced nuclear localization, we find that cyclin D1b is a poor catalyst of RB phosphorylation/inactivation. However, cyclin D1b potently induced cellular transformation in contrast to cyclin D1a. In summary, we demonstrate that cyclin D1b specifically disrupts contact inhibition in a manner distinct from cyclin D1a. These data reveal novel roles for D-type cyclins in tumorigenesis.

AB - Cyclin D1 is a proto-oncogene that functions by inactivation of the retinoblastoma tumor suppressor protein, RB. A common polymorphism in the cyclin D1 gene is associated with the production of an alternate transcript of cyclin D1, termed cyclin D1b. Both the polymorphism and the variant transcript are associated with increased risk for multiple cancers and the severity of a given cancer; however, the underlying activities of cyclin D1b have not been elucidated relative to the canonical cyclin D1a. Because cyclin D1b does not possess the threonine 286 phosphorylation site required for nuclear export and regulated degradation, it has been hypothesized to encode a stable nuclear protein that would constitutively inactivate the RB pathway. Surprisingly, we find that cyclin D1b protein does not inappropriately accumulate in cells and exhibits stability comparable to cyclin D1a. As expected, the cyclin D1b protein was constitutively localized in the nucleus, whereas cyclin D1a was exported to the cytoplasm in S-phase. Despite enhanced nuclear localization, we find that cyclin D1b is a poor catalyst of RB phosphorylation/inactivation. However, cyclin D1b potently induced cellular transformation in contrast to cyclin D1a. In summary, we demonstrate that cyclin D1b specifically disrupts contact inhibition in a manner distinct from cyclin D1a. These data reveal novel roles for D-type cyclins in tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=0041528506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041528506&partnerID=8YFLogxK

U2 - 10.1074/jbc.M303969200

DO - 10.1074/jbc.M303969200

M3 - Article

C2 - 12746453

AN - SCOPUS:0041528506

VL - 278

SP - 30339

EP - 30347

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 32

ER -